Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001651308-25-000087
Filing Date
2025-05-22
Accepted
2025-05-22 19:44:07
Documents
1
Period of Report
2025-05-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1747957441.html 4  
1 FORM 4 wk-form4_1747957441.xml 4 6615
  Complete submission text file 0001651308-25-000087.txt   8174
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Issuer) CIK: 0001651308 (see all company filings)

EIN.: 981209416 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVE, CAMANA BAY, PO BOX 1348 GRAND CAYMAN E9 KY1-1108
Business Address
Dugan Margaret (Reporting) CIK: 0001909734 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37686 | Film No.: 25978831